Meribank Biotech Co (ROCO:4724) Other Net Income (Loss) : NT$-0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Other Net Income (Loss)?

Meribank Biotech Co's Other Net Income (Loss) for the six months ended in Dec. 2023 was NT$0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.0 Mil.

Meribank Biotech Co's quarterly Other Net Income (Loss) declined from Dec. 2022 (NT$0.0 Mil) to Jun. 2023 (NT$-0.0 Mil) but then increased from Jun. 2023 (NT$-0.0 Mil) to Dec. 2023 (NT$0.0 Mil).

Meribank Biotech Co Other Net Income (Loss) Historical Data

The historical data trend for Meribank Biotech Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Other Net Income (Loss) Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial							-	-	-	-	-

Meribank Biotech Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.0 Mil.

Meribank Biotech Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines